ArticleCureus2025
Elevated B12: A Cross-Sectional Survey of Disease Associations and Attitudes of General Practitioners and Medical Students.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Elevated serum B12 (hypercobalaminaemia) has been linked to malignancies, liver disease, and increased mortality. Two additional concepts complicate interpretation. B12 pseudo-hypervitaminosis is a paradoxical state of elevated B12 in serum but intracellularly unavailable, leading to functional deficiency and B12-deficiency symptoms. Pseudo-hypercobalaminaemia is a laboratory artefact, with elevated B12 detected despite true low levels. Despite significant clinical implications, raised B12 is overlooked in primary care and medical education. This pilot study aims to assess the awareness of general practitioners (GPs) and medical students regarding the clinical implications of elevated serum B12. Methods A cross-sectional survey of 46 UK-based GPs and 50 medical students was conducted electronically using convenience sampling. The survey assessed candidates' awareness of causes, consequences, investigations, and management of high serum B12. Results Among 46 GPs, 41 (89.2%) recognised at least one disease association with hypercobalaminaemia compared to 11 (22%) of 50 medical students (p < 0.0001). Common associations included malignancy, haematological conditions, and liver pathology. Neither group demonstrated awareness of pseudo-hypercobalaminaemia or B12 pseudo-hypervitaminosis. A total of 30 (65%) GPs and 27 (54%) medical students would investigate elevated B12, yet these approaches were highly variable and frequently inappropriate. Awareness of disease associations significantly increased the likelihood of choosing an appropriate investigation (p < 0.0001). Most respondents reported receiving no formal teaching on elevated B12 levels. GPs and medical students were similar in their support for changing cancer guidelines to reflect hypercobalaminaemia, yet awareness of disease links did not significantly impact support. The qualification date of GPs did not significantly impact their awareness, investigative approaches, or attitude towards guideline changes. Conclusions This pilot survey demonstrates a clear gap in clinician understanding of hypercobalaminaemia and the lack of standardised investigative approaches. Larger, multi-centred studies are needed to develop and validate practical diagnostic pathways for primary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.